Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

NCT06584357 is registered in ClinicalTrials.gov with GAP Innovations, PBC as lead sponsor.

NCT NCT06584357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06584357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
Lead sponsor
GAP Innovations, PBC
Phase
Observational
Overall status
Recruiting
Start date
September 26, 2024
Completion date
July 31, 2028
Enrollment
1,200 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, alzheimer's disease, early onset, memory disorders, memory impairment, memory loss, mild cognitive impairment